{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T03:20:10Z","timestamp":1780716010203,"version":"3.54.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T00:00:00Z","timestamp":1764288000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T00:00:00Z","timestamp":1767052800000},"content-version":"vor","delay-in-days":32,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Key Research and Development Plan Project of Heilongjiang Province","award":["No.GA23C007"],"award-info":[{"award-number":["No.GA23C007"]}]},{"name":"the Heilongjiang Province Postdoctoral Start-up Fund","award":["No.LBH-Q20037"],"award-info":[{"award-number":["No.LBH-Q20037"]}]},{"name":"the Special Fund for Clinical Research of Wu Jie-Ping Medical Foundation","award":["No.320.6750.2022-02-16"],"award-info":[{"award-number":["No.320.6750.2022-02-16"]}]},{"name":"the 2024 Artificial Liver Special Fund","award":["No.iGandanF-1082024-RGG021"],"award-info":[{"award-number":["No.iGandanF-1082024-RGG021"]}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["No.82372172"],"award-info":[{"award-number":["No.82372172"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the Cultivation Project of Heilongjiang Provincial Natural Science Foundation","award":["No.JJ2024LH2132"],"award-info":[{"award-number":["No.JJ2024LH2132"]}]},{"name":"the Research Project of Heilongjiang Provincial Health Commission","award":["No.20231717010461"],"award-info":[{"award-number":["No.20231717010461"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"DOI":"10.1186\/s12876-025-04498-3","type":"journal-article","created":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T05:36:27Z","timestamp":1764308187000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The potential of lymphocyte\u2013C-reactive protein ratio upon admission to predict therapeutic responsiveness to mesalazine in adult patients with mild-to-moderate active ulcerative colitis"],"prefix":"10.1186","volume":"25","author":[{"given":"Chen","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-Jun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Jia","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Hui","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Lu","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Le","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Xi","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Ning","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo-Wen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,28]]},"reference":[{"key":"4498_CR1","doi-asserted-by":"publisher","first-page":"1200111","DOI":"10.3389\/fimmu.2023.1200111","volume":"14","author":"S Peng","year":"2023","unstructured":"Peng S, Shen L, Yu X, et al. The role of Nrf2 in the pathogenesis and treatment of ulcerative colitis. Front Immunol. 2023;14:1200111. https:\/\/doi.org\/10.3389\/fimmu.2023.1200111.","journal-title":"Front Immunol"},{"key":"4498_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.116722","volume":"175","author":"D Long","year":"2024","unstructured":"Long D, Mao C, Huang Y, et al. Ferroptosis in ulcerative colitis: potential mechanisms and promising therapeutic targets. Biomed Pharmacother. 2024;175:116722. https:\/\/doi.org\/10.1016\/j.biopha.2024.116722.","journal-title":"Biomed Pharmacother"},{"issue":"11","key":"4498_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.disamonth.2023.101606","volume":"69","author":"MDM Marsool","year":"2023","unstructured":"Marsool MDM, Vora N, Marsool ADM, et al. Ulcerative colitis: addressing the manifestations, the role of fecal microbiota transplantation as a novel treatment option and other therapeutic updates. Dis Mon. 2023;69(11):101606. https:\/\/doi.org\/10.1016\/j.disamonth.2023.101606.","journal-title":"Dis Mon"},{"issue":"10","key":"4498_CR4","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1016\/j.tips.2024.08.003","volume":"45","author":"P Wangchuk","year":"2024","unstructured":"Wangchuk P, Yeshi K, Loukas A. Ulcerative colitis: clinical biomarkers, therapeutic targets, and emerging treatments. Trends Pharmacol Sci. 2024;45(10):892\u2013903. https:\/\/doi.org\/10.1016\/j.tips.2024.08.003.","journal-title":"Trends Pharmacol Sci"},{"issue":"10401","key":"4498_CR5","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/S0140-6736(23)00966-2","volume":"402","author":"C Le Berre","year":"2023","unstructured":"Le Berre C, Honap S, Peyrin-Biroulet L. Ulcerative colitis. Lancet. 2023;402(10401):571\u201384. https:\/\/doi.org\/10.1016\/S0140-6736(23)00966-2.","journal-title":"Lancet"},{"issue":"4","key":"4498_CR6","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/j.gtc.2020.07.005","volume":"49","author":"L Du","year":"2020","unstructured":"Du L, Ha C. Epidemiology and pathogenesis of ulcerative colitis. Gastroenterol Clin North Am. 2020;49(4):643\u201354. https:\/\/doi.org\/10.1016\/j.gtc.2020.07.005.","journal-title":"Gastroenterol Clin North Am"},{"issue":"1","key":"4498_CR7","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/s41572-020-0205-x","volume":"6","author":"T Kobayashi","year":"2020","unstructured":"Kobayashi T, Siegmund B, Le Berre C, et al. Ulcerative colitis. Nat Rev Dis Primers. 2020;6(1):74. https:\/\/doi.org\/10.1038\/s41572-020-0205-x.","journal-title":"Nat Rev Dis Primers"},{"key":"4498_CR8","doi-asserted-by":"publisher","first-page":"998470","DOI":"10.3389\/fimmu.2022.998470","volume":"13","author":"K Chen","year":"2022","unstructured":"Chen K, Shang S, Yu S, et al. Identification and exploration of pharmacological pyroptosis-related biomarkers of ulcerative colitis. Front Immunol. 2022;13:998470. https:\/\/doi.org\/10.3389\/fimmu.2022.998470.","journal-title":"Front Immunol"},{"issue":"7","key":"4498_CR9","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1080\/17474124.2024.2383635","volume":"18","author":"X Zhang","year":"2024","unstructured":"Zhang X, Zhang X, Yang Y. Update of gut gas metabolism in ulcerative colitis. Expert Rev Gastroenterol Hepatol. 2024;18(7):339\u201349. https:\/\/doi.org\/10.1080\/17474124.2024.2383635.","journal-title":"Expert Rev Gastroenterol Hepatol"},{"issue":"19","key":"4498_CR10","doi-asserted-by":"publisher","first-page":"12117","DOI":"10.1021\/acsnano.3c11257","volume":"18","author":"S Uthaman","year":"2024","unstructured":"Uthaman S, Parvinroo S, Mathew AP, et al. Inhibiting the cGAS-STING pathway in ulcerative colitis with programmable micelles. ACS Nano. 2024;18(19):12117\u201333. https:\/\/doi.org\/10.1021\/acsnano.3c11257.","journal-title":"ACS Nano"},{"issue":"36","key":"4498_CR11","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202303457","volume":"10","author":"QW Wang","year":"2023","unstructured":"Wang QW, Jia DJ, He JM, et al. LactobacillusIntestinalis primes epithelial cells to suppress colitis-related Th17 response by host-microbe retinoic acid biosynthesis. Adv Sci. 2023;10(36):e2303457. https:\/\/doi.org\/10.1002\/advs.202303457.","journal-title":"Adv Sci"},{"issue":"2","key":"4498_CR12","doi-asserted-by":"publisher","first-page":"73","DOI":"10.3760\/cma.j.cn311367-20240125-00036","volume":"44","author":"Chinese Society of Gastroenterology, Inflammatory Bowel Disease Group; Chinese Inflammatory Bowel Disease Diagnosis and Treatment Quality Control and Evaluation Center","year":"2024","unstructured":"Chinese Society of Gastroenterology, Inflammatory Bowel Disease Group; Chinese Inflammatory Bowel Disease Diagnosis and Treatment Quality Control and Evaluation Center. Guidelines for the diagnosis and treatment of ulcerative colitis in China (2023, Xi\u2019an). Chin J Dig Dis. 2024;44(2):73\u201399. https:\/\/doi.org\/10.3760\/cma.j.cn311367-20240125-00036.","journal-title":"Chin J Dig Dis"},{"issue":"1","key":"4498_CR13","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1159\/000527452","volume":"104","author":"Y Mikami","year":"2023","unstructured":"Mikami Y, Tsunoda J, Suzuki S, et al. Significance of 5-aminosalicylic acid intolerance in the clinical management of ulcerative colitis. Digestion. 2023;104(1):58\u201365. https:\/\/doi.org\/10.1159\/000527452.","journal-title":"Digestion"},{"issue":"4","key":"4498_CR14","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1021\/acs.jproteome.2c00820","volume":"22","author":"Q Sun","year":"2023","unstructured":"Sun Q, Tang Y, Dai L, et al. Serum bile acid metabolites predict the therapeutic effect of mesalazine in patients with ulcerative colitis. J Proteome Res. 2023;22(4):1287\u201397. https:\/\/doi.org\/10.1021\/acs.jproteome.2c00820.","journal-title":"J Proteome Res"},{"key":"4498_CR15","doi-asserted-by":"publisher","first-page":"957407","DOI":"10.3389\/fimmu.2022.957407","volume":"13","author":"JN Zhang","year":"2022","unstructured":"Zhang JN, Gao Y, Wang XT, et al. Lymphocyte-C-reactive protein ratio can differentiate disease severity of COVID-19 patients and serve as an assistant screening tool for hospital and ICU admission. Front Immunol. 2022;13:957407. https:\/\/doi.org\/10.3389\/fimmu.2022.957407.","journal-title":"Front Immunol"},{"issue":"9","key":"4498_CR16","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1080\/1744666X.2024.2385765","volume":"20","author":"Y Wang","year":"2024","unstructured":"Wang Y, Lin Y, Zhang L, et al. Lymphocyte-C-reactive protein ratio combined with albumin upon admission predicts coronary artery dilation and aneurysm formation in pediatric patients with Kawasaki disease: a retrospective cohort study. Expert Rev Clin Immunol. 2024;20(9):1127\u201333. https:\/\/doi.org\/10.1080\/1744666X.2024.2385765.","journal-title":"Expert Rev Clin Immunol"},{"key":"4498_CR17","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2022.867692","volume":"9","author":"R Li","year":"2022","unstructured":"Li R, Huang X, Yang L, et al. Integrated analysis reveals the targets and mechanisms in immunosuppressive effect of mesalazine on ulcerative colitis. Front Nutr. 2022;9:867692. https:\/\/doi.org\/10.3389\/fnut.2022.867692.","journal-title":"Front Nutr"},{"key":"4498_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2023.123196","volume":"642","author":"M Wei","year":"2023","unstructured":"Wei M, Liu D, Sun Y, et al. Mesalazine hollow suppositories based on 3D printing for treatment of ulcerative colitis. Int J Pharm. 2023;642:123196. https:\/\/doi.org\/10.1016\/j.ijpharm.2023.123196.","journal-title":"Int J Pharm"},{"issue":"3","key":"4498_CR19","doi-asserted-by":"publisher","first-page":"300060524123627","DOI":"10.1177\/03000605241236278","volume":"52","author":"D Wang","year":"2024","unstructured":"Wang D, Gao Y, Lai QQ, et al. Dynamic lymphocyte-CRP ratio as a predictor: a single-centre retrospective study on disease severity and progression in adult COVID-19 patients. J Int Med Res. 2024;52(3):3000605241236278. https:\/\/doi.org\/10.1177\/03000605241236278.","journal-title":"J Int Med Res"},{"key":"4498_CR20","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.2147\/JIR.S450587","volume":"17","author":"XY Xu","year":"2024","unstructured":"Xu XY, Gao Y, Yue CS, et al. Predictive and prognostic potentials of Lymphocyte-C-Reactive protein ratio upon hospitalization in adult patients with acute pancreatitis. J Inflamm Res. 2024;17:1659\u201369. https:\/\/doi.org\/10.2147\/JIR.S450587.","journal-title":"J Inflamm Res"},{"issue":"1","key":"4498_CR21","doi-asserted-by":"publisher","first-page":"3012","DOI":"10.1038\/s41598-024-84054-3","volume":"15","author":"YJ Hu","year":"2025","unstructured":"Hu YJ, Qiu SX, Zhang JN, et al. Lymphocyte-C-reactive protein ratio upon admission to predict disease progression and ICU admission in adult patients with diabetic ketoacidosis. Sci Rep. 2025;15(1):3012. https:\/\/doi.org\/10.1038\/s41598-024-84054-3.","journal-title":"Sci Rep"},{"issue":"2","key":"4498_CR22","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1097\/SLA.0000000000003239","volume":"272","author":"Y Okugawa","year":"2020","unstructured":"Okugawa Y, Toiyama Y, Yamamoto A, et al. Lymphocyte-C-reactive protein ratio as promising new marker for predicting surgical and oncological outcomes in colorectal cancer. Ann Surg. 2020;272(2):342\u201351. https:\/\/doi.org\/10.1097\/SLA.0000000000003239.","journal-title":"Ann Surg"},{"issue":"2","key":"4498_CR23","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1111\/liv.14567","volume":"41","author":"LH Lu","year":"2021","unstructured":"Lu LH, Zhong C, Wei W, et al. Lymphocyte-C-reactive protein ratio as a novel prognostic index in intrahepatic cholangiocarcinoma: a multicentre cohort study. Liver Int. 2021;41(2):378\u201387. https:\/\/doi.org\/10.1111\/liv.14567.","journal-title":"Liver Int"},{"key":"4498_CR24","doi-asserted-by":"publisher","DOI":"10.1177\/20406223241259654","volume":"15","author":"Y Lu","year":"2024","unstructured":"Lu Y, Xiong S, Zhang M, et al. Long-term outcomes and associated factors of Crohn\u2019s disease patients achieving transmural healing based on magnetic resonance enterography: a Chinese retrospective cohort study. Ther Adv Chronic Dis. 2024;15:20406223241259654. https:\/\/doi.org\/10.1177\/20406223241259654.","journal-title":"Ther Adv Chronic Dis"},{"issue":"36","key":"4498_CR25","doi-asserted-by":"publisher","first-page":"3203","DOI":"10.11569\/wcjd.v25.i36.3203","volume":"25","author":"H Jun","year":"2017","unstructured":"Jun H, Huangwei C, Min Z, et al. Evaluation of the efficacy of different administration methods of mesalazine in the treatment of ulcerative colitis. World Chin J Digestology. 2017;25(36):3203\u201310. https:\/\/doi.org\/10.11569\/wcjd.v25.i36.3203.","journal-title":"World Chin J Digestology"},{"issue":"10","key":"4498_CR26","doi-asserted-by":"publisher","first-page":"e2231480","DOI":"10.1001\/jamanetworkopen.2022.31480","volume":"5","author":"B Thomson","year":"2022","unstructured":"Thomson B, Emberson J, Lacey B, et al. Association between smoking, smoking cessation, and mortality by race, ethnicity, and sex among US adults. JAMA Netw Open. 2022;5(10):e2231480. https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.31480.","journal-title":"JAMA Netw Open"},{"issue":"4","key":"4498_CR27","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/j.gtc.2020.07.001","volume":"49","author":"T Kaenkumchorn","year":"2020","unstructured":"Kaenkumchorn T, Wahbeh G. Ulcerative colitis: making the diagnosis. Gastroenterol Clin North Am. 2020;49(4):655\u201369. https:\/\/doi.org\/10.1016\/j.gtc.2020.07.001.","journal-title":"Gastroenterol Clin North Am"},{"issue":"24","key":"4498_CR28","doi-asserted-by":"publisher","first-page":"4216","DOI":"10.2174\/0929867329666211227121321","volume":"29","author":"AC Maio","year":"2022","unstructured":"Maio AC, Basile G, Iacopetta D, et al. The significant role of nutraceutical compounds in ulcerative colitis treatment. Curr Med Chem. 2022;29(24):4216\u201334. https:\/\/doi.org\/10.2174\/0929867329666211227121321.","journal-title":"Curr Med Chem"},{"key":"4498_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.116891","volume":"176","author":"W Zhang","year":"2024","unstructured":"Zhang W, Zou M, Fu J, et al. Autophagy: a potential target for natural products in the treatment of ulcerative colitis. Biomed Pharmacother. 2024;176:116891. https:\/\/doi.org\/10.1016\/j.biopha.2024.116891.","journal-title":"Biomed Pharmacother"},{"issue":"10","key":"4498_CR30","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1001\/jama.2023.15389","volume":"330","author":"B Gros","year":"2023","unstructured":"Gros B, Kaplan GG. Ulcerative colitis in adults: a review. JAMA. 2023;330(10):951\u201365. https:\/\/doi.org\/10.1001\/jama.2023.15389.","journal-title":"JAMA"},{"issue":"4","key":"4498_CR31","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1080\/14712598.2019.1666101","volume":"20","author":"C Le Berre","year":"2020","unstructured":"Le Berre C, Roda G, Nedeljkovic Protic M, et al. Modern use of 5-aminosalicylic acid compounds for ulcerative colitis. Expert Opin Biol Ther. 2020;20(4):363\u201378. https:\/\/doi.org\/10.1080\/14712598.2019.1666101.","journal-title":"Expert Opin Biol Ther"},{"issue":"7","key":"4498_CR32","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1093\/ecco-jcc\/jjab010","volume":"15","author":"B Barberio","year":"2021","unstructured":"Barberio B, Segal JP, Quraishi MN, et al. Efficacy of oral, topical, or combined oral and topical 5-aminosalicylates, in ulcerative colitis: systematic review and network meta-analysis. J Crohns Colitis. 2021;15(7):1184\u201396. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjab010.","journal-title":"J Crohns Colitis"},{"issue":"4","key":"4498_CR33","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1097\/MOG.0000000000001023","volume":"40","author":"T Nagaraj","year":"2024","unstructured":"Nagaraj T, Shinn J, De Felice K. A practical guide to selecting and using new ulcerative colitis therapies. Curr Opin Gastroenterol. 2024;40(4):235\u201342. https:\/\/doi.org\/10.1097\/MOG.0000000000001023.","journal-title":"Curr Opin Gastroenterol"},{"issue":"26","key":"4498_CR34","doi-asserted-by":"publisher","first-page":"2444","DOI":"10.1056\/NEJMoa2207940","volume":"388","author":"G D\u2019Haens","year":"2023","unstructured":"D\u2019Haens G, Dubinsky M, Kobayashi T, et al. Mirikizumab as induction and maintenance therapy for ulcerative colitis. N Engl J Med. 2023;388(26):2444\u201355. https:\/\/doi.org\/10.1056\/NEJMoa2207940.","journal-title":"N Engl J Med"},{"issue":"10","key":"4498_CR35","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1016\/j.dld.2023.05.021","volume":"55","author":"K Mpakogiannis","year":"2023","unstructured":"Mpakogiannis K, Fousekis FS, Christodoulou DK, et al. The current role of Tofacitinib in acute severe ulcerative colitis in adult patients: a systematic review. Dig Liver Dis. 2023;55(10):1311\u20137. https:\/\/doi.org\/10.1016\/j.dld.2023.05.021.","journal-title":"Dig Liver Dis"},{"issue":"47","key":"4498_CR36","doi-asserted-by":"publisher","first-page":"6111","DOI":"10.3748\/wjg.v29.i47.6111","volume":"29","author":"N Ishida","year":"2023","unstructured":"Ishida N, Ito T, Takahashi K, et al. Comparison of fecal calprotectin levels and endoscopic scores for predicting relapse in patients with ulcerative colitis in remission. World J Gastroenterol. 2023;29(47):6111\u201321. https:\/\/doi.org\/10.3748\/wjg.v29.i47.6111.","journal-title":"World J Gastroenterol"},{"key":"4498_CR37","doi-asserted-by":"publisher","unstructured":"Di Ruscio M, Variola A, Vernia F, et al. Role of Ulcerative Colitis Endoscopic Index of Severity (UCEIS) versus Mayo Endoscopic Subscore (MES) in Predicting Patients' Response to Biological Therapy and the Need for Colectomy. Digestion. 2021;102(4):534-545. https:\/\/doi.org\/10.1159\/000509512","DOI":"10.1159\/000509512"},{"issue":"1","key":"4498_CR38","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/s12876-022-02157-5","volume":"22","author":"A Viscido","year":"2022","unstructured":"Viscido A, Valvano M, Stefanelli G, et al. Systematic review andmeta-analysis: the advantage of endoscopic Mayo score 0 over 1 inpatients with ulcerative colitis. BMC Gastroenterol. 2022;22(1):92. https:\/\/doi.org\/10.1186\/s12876-022-02157-5.","journal-title":"BMC Gastroenterol."},{"key":"4498_CR39","doi-asserted-by":"publisher","first-page":"175628482311709","DOI":"10.1177\/17562848231170945","volume":"16","author":"J Qi","year":"2023","unstructured":"Qi J, Ruan G, Ping Y, et al. Development and validation of a deep learning-based approach to predict the Mayo endoscopic score of ulcerative colitis. Therap Adv Gastroenterol. 2023;16:17562848231170944. https:\/\/doi.org\/10.1177\/17562848231170945.","journal-title":"Therap Adv Gastroenterol."},{"issue":"4","key":"4498_CR40","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1002\/jgh3.12023","volume":"1","author":"S Jain","year":"2017","unstructured":"Jain S, Kedia S, Bopanna S, et al. Left-sided colitis and extensive colitis have similar colectomy rates after index episode of acute severe colitis: A long-term follow-up study. JGH Open. 2017;1(4):134\u20139. https:\/\/doi.org\/10.1002\/jgh3.12023.","journal-title":"JGH Open."}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-025-04498-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-025-04498-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-025-04498-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T05:43:02Z","timestamp":1767073382000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12876-025-04498-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,28]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4498"],"URL":"https:\/\/doi.org\/10.1186\/s12876-025-04498-3","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,28]]},"assertion":[{"value":"16 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was reviewed and approved by the Ethics Committee of the Second Affiliated Hospital of Harbin Medical University (IRB number: KY2025-010). In accordance with the Declaration of Helsinki, the medical data required for this study, obtained by the dedicated personnel within our research team from the Medical Record Department of the Second Affiliated Hospital of Harbin Medical University, had been removed the personal information of the enrolled patients. Therefore, written informed consent from the study participants was waived in compliance with institutional requirements.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"895"}}